Guan Wang
Impact in
- Cancer Research top 2%
- Molecular Biology top 2%
- Protein Degradation and Inhibitors
- Angiogenesis and VEGF in Cancer
- Ubiquitin and proteasome pathways
- RNA modifications and cancer
- Epigenetics and DNA Methylation
Papers in
-
- Protein Degradation and Inhibitors 17
- Histone Deacetylase Inhibitors Research 13
- Epigenetics and DNA Methylation 12
- Melanoma and MAPK Pathways 11
- Ubiquitin and proteasome pathways 10
- Oncology 32
- Co-authors
- Liang Ouyang (50 shared papers)Richard Kendall (1 shared paper)Kenneth A. Thomas (1 shared paper)Lu Feng (8 shared papers)Bo Liu (12 shared papers)Lan Zhang (11 shared papers)Junping Pei (10 shared papers)Yuan Liu (1 shared paper)
- Journals
- Journal of Medicinal Chemistry (22 papers)European Journal of Medicinal Chemistry (16 papers)Acta Pharmaceutica Sinica B (7 papers)Bioorganic Chemistry (5 papers)Oncotarget (4 papers)
- Partner nations
- ChinaUnited StatesThailand
In The Last Decade
Guan Wang
213 papers receiving 6.3k citations
Guan Wang's Hit Papers
Peers
Comparison fields: 5 of 171
- Cancer Research 653
- Molecular Biology 3.0k
- Oncology 842
- Geriatrics and Gerontology 82
- Obstetrics and Gynecology 165
Countries citing papers authored by Guan Wang
This map shows the geographic impact of Guan Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guan Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guan Wang more than expected).
Fields of papers citing papers by Guan Wang
This network shows the impact of papers produced by Guan Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guan Wang. The network helps show where Guan Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Guan Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 220 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Identification of a Natural Soluble Form of the Vascular Endothelial Growth Factor Receptor, FLT-1, and Its Heterodimerization with KDR Hit paper breakdown → | 1996 | 629 |
| 2 | 2017 | 227 | |
| 3 | Oxygenated phosphatidylethanolamine navigates phagocytosis of ferroptotic cells by interacting with TLR2 Hit paper breakdown → | 2021 | 198 |
| 4 | ALOX15-launched PUFA-phospholipids peroxidation increases the susceptibility of ferroptosis in ischemia-induced myocardial damage Hit paper breakdown → | 2022 | 193 |
| 5 | 2017 | 166 | |
| 6 | 2021 | 116 | |
| 7 | 2021 | 116 | |
| 8 | 2022 | 110 | |
| 9 | 2020 | 109 | |
| 10 | 2011 | 108 | |
| 11 | 2020 | 105 | |
| 12 | 2022 | 98 | |
| 13 | 2020 | 98 | |
| 14 | 2019 | 97 | |
| 15 | 2021 | 97 | |
| 16 | 2021 | 96 | |
| 17 | 2023 | 86 | |
| 18 | 2013 | 85 | |
| 19 | 2017 | 84 | |
| 20 | 2021 | 83 |
About Guan Wang
Guan Wang is a scholar working on Molecular Biology, Oncology, Organic Chemistry, Epidemiology and Pharmacology, having authored 220 papers that have together received 6.4k indexed citations. Recurring topics across this work include Autophagy in Disease and Therapy (17 papers), Protein Degradation and Inhibitors (17 papers), Histone Deacetylase Inhibitors Research (13 papers), Epigenetics and DNA Methylation (12 papers), Melanoma and MAPK Pathways (11 papers), Ubiquitin and proteasome pathways (10 papers), Advanced Battery Materials and Technologies (9 papers) and Computational Drug Discovery Methods (9 papers). The work is most often cited by research in Cancer Research (653 citations), Molecular Biology (3.0k citations), Oncology (842 citations), Geriatrics and Gerontology (82 citations) and Obstetrics and Gynecology (165 citations). Guan Wang has collaborated with scholars based in China, United States and Thailand. Frequent co-authors include Liang Ouyang, Richard Kendall, Kenneth A. Thomas, Lu Feng, Bo Liu, Lan Zhang, Junping Pei, Yuan Liu, Yu Sun and Haiyan Zhang. Their work appears in journals such as Journal of Medicinal Chemistry, European Journal of Medicinal Chemistry, Acta Pharmaceutica Sinica B, Bioorganic Chemistry and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.